chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had a fever that went for 2 days and got up to 105 and would not go down with Advil/Tylenol, bath and had it for more than 2 days, also had a huge lump on the Left side of her neck
Mild hives on left forearm day 1, took loratidine. Moderate hives on both forearms after 7 days. Continue to have itchy legs and hives in forearms.
Tinnitus (Continuous), Raised derma acute on the right side of the neck, just above the lymph nodes. Also expressed on the left side but to a smaller degree. Across the top of the head in a thin line of raised bumps. Continuous Nausa at rest and when in motion as in a car. Numbness in the hands in the morning and weakness at the joints. A the fist shot on 4/25/21, the bumps showed up but went down, then the second shot and the bumps, Nausa, and confusion went way up and stayed there.
We recently had COVID Again; We recently had COVID Again; I have lost my sense of taste/ smell, for the 2nd time; I have lost my sense of taste/ smell, for the 2nd time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in May2023 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Suspected COVID-19" (unspecified if ongoing); "I have lost my sense of taste/ smell" (unspecified if ongoing); "I have lost my sense of taste/ smell" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: ANOSMIA (non-serious), AGEUSIA (non-serious) all with onset 2023, outcome "unknown" and all described as "I have lost my sense of taste/ smell, for the 2nd time"; DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "We recently had COVID Again". Clinical course: The patient and her husband had received all shots for Covid, had Covid again and patient had lost all her senses of taste/smell for 2nd time.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300229697 same reporter/drug and different patient/events.;
None. Pfizer lot GK1657  expired 10/25/2022, given on 3/20/2023
Left Deltoid with edema, erythema, itching; employee C/O arm with numbness.
Begining night of vaccine7/9/2020; arm warmth/sore, hot/cold spells, extreme tiredness. These symptoms lasted through 7/13/2020.
no adverse event; the patient was administered the first dose of GARDASIL in the series 2 years ago at age 16 (date unspecified). The patient is now returning to complete the series at age 18; the patient was administered the first dose of GARDASIL in the series 2 years ago at age 16 (date unspecified). The patient is now returning to complete the series at age 18; This spontaneous report was received from a physician, referring to an 18-year-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On an unspecified date in 2019 (also reported as 2 years ago at age 16), the patient was vaccinated with the first dose in the series of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, at a dose of 0.5 milliliter (ml) (strength, frequency, anatomical site of vaccination, route of administration, lot number and expiration date were not reported) as prophylaxis.  On an unspecified date in 2021 (also reported as now), the patient was returning to complete the series at age 18 (inappropriate schedule of product administration and circumstance or information capable of leading to medication error). No additional adverse effect (AE).
Two days after receiving shingles vaccine, patient started having numbness and tingling to  left hand involving his fingers mostly left thumb and index but also 3rd, 4th, and 5th fingers.  Numbness and tingling  lasts an hour and occurs several times a day.  Patient does have  remote history of surgery for fractured left forearm in 2004 but day before shingles vaccine he did not have the current symptoms.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 16-MAY-2018, the patient was vaccinated with an improperly stored dose of Oka-Merck PROQUAD albumin status: recombinant human albumin (rHA) (dose, anatomical location and route of administration were not reported) lot # N025926, expiration date: 18-MAR-2019 indicated for prophylaxis which was reconstituted with MERCK STERILE DILUENT properly stored. No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 30 minutes on unspecified date called by a data logger. There were previous excursions reported of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 45 minutes. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1806USA002429.
Patient received her booster- and right after she received her vaccines about 2-3 minutes she reports feeling lightheaded and dizzziness-  passed out for about 3-5 secwe lower her down the floor and elevated her legs to keep her pressure to vital organ- Checked her BP was within range- Heart rate 53, BP 113/66- alert and oriented-
About 1-2 hrs after vaccination, while driving, lost consciousness, crashing into a car and mailboxes before regaining consciousness. 01/31/07-records received and reviewed.  Neuro consult 1/17/07.  Assessment:episodes of loss of consciousness. Differential diagnoses could include Juvenile Myoclonic Epilepsy, complicated migraine or cardiac arrhythmia. Holter monitor to evaluate for dysrhythmia.  Psychotherapy with respect to her depression and medical management.  PMH:This past summer had an episode where she suddenly got dizzy with the onset of sharp headache and then lost consciousness. She go back up and then blacked out again. No tongue biting or urinary incontinence. Disorientation lasted few minutes. Felt tired and achy but no further dizziness. In October 2006, episode of dizziness without loss of consciousness. Lips turned blue and whole body numb and tingling, greater on right side than left side. Head injury in October with concussion, confusion and dazed afterwards. EEG in October 2002 normal, MRI in March 2003 normal. On 1/15/07 while driving she was unaware that she had hit two mailboxes and a car. Half hour before accident she received HPV and noted swelling and throbbing at injection site. Experienced headache with this. Reports some occasional body jerks, especially noted at night when she is tired.  PMH: depression, migraines which started in middle school, eczema, asthma and chicken pox.
About 2 weeks after vaccination and still continuing, head and neck pain. Running up neck to the back of head all the way to the top of head in the back.
A dose of VAQTA was given "too soon" / first dose of VAQTA was received when patient "was 12 months old and second dose was given when patient was only 17 months old"; No adverse effects reported; This spontaneous report was received from a licensed practical nurse referring to a 17 months old patient of unknown gender. The patient's concurrent conditions, past medical history, concomitant medications, and drug reactions or allergies were not reported.  On an unknown date, when the patient was 12 months old, he/she was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) vial 50, intramuscular (dose, anatomical location, lot # and expiration date were not reported), for prophylaxis.  Subsequently, on an unknown date, when the patient was 17 months old, the patient received the second dose of hepatitis a vaccine, inactivated (VAQTA). It was reported that the dose was given "too soon". No adverse effects reported.
12 hours after receiving the covid vaccine I had a sudden onset of the following symptoms:  extremely flushed in arms, chest and face,  clammy, both my arms swelled and were very red.  the arm with the injection site swelled more than the non-injection arm.  Itchy all over and what seemed to be hives formed on inside of both arms.  I was itchy and prickly behind both knees, inside of elbows, and under breasts, and top of stomach.   I was NOT wheezing and NO trouble breathing.  I did NOT have any fever.  I took 2 over the counter benadryl. The symptoms subsided substantially within an hour, but did not go away completely.  The next morning, swelling is down, redness is down, slight hives/rash on inside elbow of NON vaccinated arm.  Feel fine overall.
Itching/redness, 6 to 8 hours after injection, ice hydrocortisone cream.
I experienced COVID-19 symptoms two weeks after my vaccine. I experienced terrible runny nose, scratchy throat, wet mixed and dry cough and a bit of fever for one day. Today it is better, my throat already feels a lot better. The doctor prescribed LAGEVRIO medication. I did a home test COVID-19 test on 10/22/2022. I am still recovering at this time.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Nurse).  An 81-year-old male patient received BNT162b2 (BNT162B2), on 25Feb2021 as dose 1, single (Lot number: EN6198), on 18Mar2021 as dose 2, single (Lot number: EP7534) and on 04Oct2021 as dose 3 (booster), single (Lot number: FE3590) at the age of 81 years for covid-19 immunisation. The patient's relevant medical history included: "Stage 3 CKD" (unspecified if ongoing); "major depressive disorder" (unspecified if ongoing); "controlled T2DM" (unspecified if ongoing); "hypercoagulability due to atrial fibrillation" (unspecified if ongoing); "atrial fibrillation" (unspecified if ongoing); "Severe obesity" (unspecified if ongoing); "dementia with behavioural disturbance" (unspecified if ongoing); "Behavioural disturbance" (unspecified if ongoing); "GERD" (unspecified if ongoing); "Benign HTN" (unspecified if ongoing); "mild concentric left ventricular hypertrophy" (unspecified if ongoing). Concomitant medication(s) included: ASPIRIN 81; BUSPIRONE; GABAPENTIN; MEMANTINE HCL; METFORMIN; METOPROLOL; OXYCODONE; QUETIAPINE; ROSUVASTATIN; WARFARIN. Past drug history included: Morphine, reaction(s): "Known allergies: Morphine"; Codeine, reaction(s): "Known allergies: Codeine". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included treatment with paxlovid from 14Jul2022 to 16Jul2022.  Clinical course: It was reported that the patient took other medications in 2 weeks.; Sender's Comments: Based on the available reported information, the causal association between the events and the suspect drug BNT162B2 cannot be excluded.
Arm where PNEUMOVAX 23 administered got red, hot, swollen and painful from shoulder to elbow. KEFLEX 500mg qid x 10 days.
Feeling horrible; COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) and FEELING ABNORMAL (Feeling horrible) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. Concurrent medical conditions included Immunocompromised. On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In July 2022, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced FEELING ABNORMAL (Feeling horrible). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) and FEELING ABNORMAL (Feeling horrible) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2022, SARS-CoV-2 test: (Positive) Positive and (Positive) Positive. On an unknown date, Body temperature: 103 103 F. No concomitant product use was provided. The patient tested positive after getting the second booster shot two days before reporting. Patient tested herself twice and both got positive results. She said she was too sick to move to get her vaccination card. Patient experienced symptoms of COVID-19 included Bad cough, Sore throat, Fever at 103F and Body aches. Company comment: This spontaneous case concerns a 63 year old female immunocompromised patient, with no other medical history reported, who experienced the unexpected, non-serious Adverse Event of Special Interest of COVID-19, which occurred unknown days after the second booster shot of mRNA-1273 vaccine administration. Patient experienced symptoms of COVID-19 included Bad cough, Sore throat, Fever at 103F and Body aches. No treatment medication were reported. The ongoing COVID-19 pandemic could be a confounder for the event COVID-19. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Sender's Comments: This spontaneous case concerns a 63 year old female immunocompromised patient, with no other medical history reported, who experienced the unexpected, non-serious Adverse Event of Special Interest of COVID-19, which occurred unknown days after the second booster shot of mRNA-1273 vaccine administration. Patient experienced symptoms of COVID-19 included Bad cough, Sore throat, Fever at 103F and Body aches. No treatment medication were reported. The ongoing COVID-19 pandemic could be a confounder for the event COVID-19. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Rash; irritation; swelling at injection site; headache; This is a spontaneous report from a contactable consumer (patient). A 61-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6201), dose 1 via an unspecified route of administration, administered in right arm on 16Feb2021 14:45 (at the age of 61-year-old) as single for covid-19 immunisation. Medical history included high blood pressure, asthma, seasonal allergies and Penicillin allergy (z pack) from an unknown date and unknown if ongoing. Patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient neither diagnosed with COVID-19 prior to vaccination nor tested since the vaccination. Concomitant medications included amlodipine besilate (AD [AMLODIPINE BESILATE]) 5 mg, montelukast 10 mg and fexofenadine hydrochloride (ALLEGRA) - all taken for an unspecified indication, start and stop date were not reported. On 17Feb2021 18:30 the patient experienced rash, irritation, swelling at injection site and headache. No treatment was received for the events. Outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
got GBS; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was unknown.   The reporter considered the guillain barre syndrome to be possibly related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The reporter stated that they would tell you Guillain Barre syndrome was very rare, but the reporter knows the patient who had Guillain Barre syndrome. The reporter stated that he/she would never take the Shingles shot because it could cause Guillain Barre syndrome (GBS). The shot tells you that in the fine print. This case was 1 of the 4 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR208069:same reporter US-GLAXOSMITHKLINE-US2021AMR208073:same reporter US-GLAXOSMITHKLINE-US2021AMR208071:same reporter
developed gout; left toe joint pain; left toe joint pain; a swollen foot; This is a spontaneous report from a contactable consumer. This consumer reported that a 63-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on 15Apr2021 as single dose for COVID-19 immunization. Medical history included he had an episode of gout last year but it only lasted one day. Concomitant medications were not reported. The patient received bnt162b2 and the next day he developed gout including left toe joint pain and a swollen foot. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Approximately 20 hours after vaccination had generalized weakness, new onset leading to fall. Evaluated on day of fall which is today, noted to have mild generalized weakness, headache with no other new neurological abnormality noted.
Subjective low grade fever, chills and feeling like she had the "flu" the day after the vaccine.  Also noted body aches and that her skin on right thigh felt more "sensitive" the day after the vaccine.  A few days later herpes zoster rash developed on right thigh where the skin sensitivity was located.
Patient received the 1st dose of Moderna on 03/29/21 with no immediate reactions. The patient presented to the emergency room 04/03/2021 with high blood pressure, pulse, and chest pain.
Lightheaded while walking in store after vaccine. Got worse when got home. By 8pm, arm was so sore that could hardly lift it up, hot to touch. Bu midnight, she couldn't touch left arm because it was so sore. Patient had fever at night because woke up sweating. Did not sleep well at all. Next morning left arm was sore when woke up. Arm was red around arm all the way to elbow; area was warm. Had fever all day. At night took ibuprofen (2 tablets) to be able to sleep. Did not feel like eating much all day. Today feels like getting better. Right arm just had a little soreness. A safe-barrier bandage was used for both vaccines. Pt has not called vaccine administrator yet.
This spontaneous report was received from a physician via company representative and refers to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On an unknown date, the patient was vaccinated with her second dose of GARDASIL 9, by intramuscular route, (strength, dose, anatomical location, lot number and expiration date were not reported), for prevent HPV. No other suspect or concomitant therapies were reported. On an unknown date, the patient experienced "hives on her chest" (urticaria). The patient sought medical attention and contacted her physician, however, it was unclear if the patient received any treatment  for her event. No product quality complain was involved. At the time of reporting, the outcome of urticaria was unknown, and, the reporter did not assess the causal relationship between the urticaria and the therapy with GARDASIL 9.  Additional information has been requested.
Red blotchy skin in arm that received vaccination. Warm to touch, a little sore. Began 7 days after injection, resolved 5 days later. As of this report, arm is no longer red, warm or sore to touch.
Both legs noted with dark , nodules/lumps underneath the skin. It started in June . The nodules keeps on growing on my both legs, back of the shern, feet, ankles. It is tender to touch, lumps are hard to touch, dark in appearance, some skins are red in appearance. I am in pain. I do prolonged standing on my work & i never had this problem before. No new medications was given to me, after I received the vaccine, 4 months after, my legs have a lot of nodules, scattered on my legs.
Anaphylactic shock 07/05/2016 7:00 a.m. BENADRYL injection by EMS. NSIV and Prednisone in ED. Allergy testing and asthma testing and treatment. Allergy medications and shots incl. carry EPIPEN at all times.
Within a few minutes, I got an intense migraine. I was really lightheaded. I had shooting pains in my head and in my eye. I had to take both my migraine meds and an injection. No matter what I took, the symptoms did not ease for five days.
This spontaneous report was received from a office manager and refers to a 12-months-old female patient. On 12-APR-2018, the patient was vaccinated for prophylaxis with improperly stored dose of VARIVAX (lot number N029631, expiration date 23-OCT-2019) (dose and route of administration were not provided), reconstituted with properly stored sterile diluent. The vaccine underwent a temperature excursion of 12 degrees Fahrenheit for 30 minutes. There was no previous temperature of excursion reported. Digital data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter.
Information has been received from a health professional referring to a patient of unknown age and gender. Information about medical history and concurrent conditions were unspecified. On 19-SEP-2015, the patient was vaccinated with an expired dose of RECOMBIVAX HB (lot # J000722, expiration date 17-SEP-2015, dose and route were unknown). No known adverse effects were reported. This is one of two reports received from the same patient. Additional information has been requested.
The medical assistant reported that one dose of expired MMR II was administered to the patient.; No adverse effects were reported.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.  On 17-MAY-2019, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) 1 dose (strength, route, dose, frequency, and anatomical location were unknown) with  lot # N014486 and expiration date 10-MAY-2019 for prophylaxis reconstituted with a sterile diluent. No adverse effects were reported.
My Fever lasted From Tuesday evening until Friday evening. It ranged from 99.2 through 103.4. It stayed between 101.0-103.4 even taking Tylenol from 101.0-103.4 until Friday morning and finally broke. I had a throbbing headache, shaking chills, and felt very weak to the point of feeling very dizzy. I was very weak through Saturday afternoon. I did have a  red rash and itching at the injection site at least an inch in diameter .for 6 days. I was very tired from staying up the night before the vaccine with my mom who has dementia .
A report was received from a health care professional on 10/21/2002, concerning a 38 year old female vaccinee who experienced a large welt over the deltoid region of her arm which was described as red and swollen, and the armpit gland was reported as sore on 10/16/02, after receiving 0.5 ml Fluvirin on 10/15/02. The vaccinee was reported as recovered since 10/18/02. There was insufficient information to determine the reporter's causality assessment. Ref: PJP200200601, PJP200200598, PJP200200597, PJP200200596.
Nausea, feeling of need to vomit, malaise, tightness in chest, pain at vaccination site throughout night and into following morning.